The DOI matches its Crossref record; 208 of the 212 references it cites were found in a registry or an index.
Biomarkers for depression: recent insights, current challenges and future prospects
Open accessAbstract
Abstract: A plethora of research has implicated hundreds of putative biomarkers for depression, but has not yet fully elucidated their roles in depressive illness or established what is abnormal in which patients and how biologic information can be used to enhance diagnosis, treatment and prognosis. This lack of progress is partially due to the nature and heterogeneity of depression, in conjunction with methodological heterogeneity within the research literature and the large array of biomarkers with potential, the expression of which often varies according to many factors. We review the available literature, which indicates that markers involved in inflammatory, neurotrophic and metabolic processes, as well as neurotransmitter and neuroendocrine system components, represent highly promising candidates. These may be measured through genetic and epigenetic, transcriptomic and proteomic, metabolomic and neuroimaging assessments. The use of novel approaches and systematic research programs is now required to determine whether, and which, biomarkers can be used to predict response to treatment, stratify patients to specific treatments and develop targets for new interventions. We conclude that there is much promise for reducing the burden of depression through further developing and expanding these research avenues. Keywords: mood disorder, major depressive disorder, inflammation, treatment response, stratification, personalized medicine
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The serum VEGF level was found to be increased in depressed patients compared with that of control subjects in 16 studies.”
From Study protocol on the efficacy of exergames-acceptance and commitment therapy program for the treatment of major depressive disorder: Comparison with acceptance and commitment therapy alone and treatment-as-usual in a multicentre randomised controlled trial (2024) · cites this paper as [16]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Part of this paper’s reference list could not be split into single entries.
Items 201–208 of 208
HPA Axis Modulation in the Treatment of Mood Disorders
Lauren, B., & Charles, B. (2013) · InTech eBooks · doi:10.5772/51600 · Cited by 9
Masato, Y., & Atake, K. (2016) · Journal of Depression & Anxiety · doi:10.4172/2167-1044.1000222 · Cited by 5
Otte, C., Hinkelmann, K., Moritz, S., Yassouridis, A., Jahn, H., Wiedemann, K., & Kellner, M. B. (2009) · Pharmacopsychiatry · doi:10.1055/s-0029-1240192 · Cited by 5
Role of corticosteroids in the antidepressant response
Pierscionek, T. J., Adekunte, O., Watson, S., Ferrier, I. N., & Alabi, A. (2014) · ChronoPhysiology and Therapy · doi:10.2147/cpt.s67272 · Cited by 4
Hiles, S. A., Attia, J., & Baker, A. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.07.147 · Cited by 4
Lewis, S. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3830 · Cited by 3
Parity of publication for psychiatry
Vivekanantham, S., Strawbridge, R., Rampuri, R., Ragunathan, T., & Young, A. H. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.165118 · Cited by 3
Self-citationYates, D. M. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3834 · Cited by 2
Research works printed but not linked: 2
- Krishnadas R, Cavanagh J. Depression: an inflammatory illness? J Neurol Neurosurg Psychiatry. 2012;83(5):495-502.
- Xia Q, Wang G, Wang H, Xie Z, Fang Y, Li Y. Study of metabolism of glucose and lipid in patients of first-episode depressioon. J Clin Psychiatry. 2009;19:241-243.
Cited by
Sorted by citations
Sleep, insomnia, and depression
Riemann, D. W., Krone, L. B., Wulff, K., & Nissen, C. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0411-y · Cited by 901
Jesulola, E., Micalos, P., & Baguley, I. J. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.025 · Cited by 379
Biological Sex Differences in Depression: A Systematic Review
Labaka, A., Goñi‐Balentziaga, O., Lebeña, A., & Pérez-Tejada, J. (2018) · Biological Research For Nursing · doi:10.1177/1099800418776082 · Cited by 297
Impact of COVID-19 in the Mental Health in Elderly: Psychological and Biological Updates
Grolli, R. E., Mingoti, M. E. D., Bertollo, A. G., Luzardo, A. R., Quevedo, J., Réus, G. Z., & Ignácio, Z. M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02249-x · Cited by 286
Heart Rate Variability as Indicator of Clinical State in Depression
Hartmann, R., Schmidt, F. M., Sander, C., & Hegerl, U. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00735 · Cited by 262
Metadata
- Authors
- Strawbridge, R., Young, A. H., & Cleare, A. J.
- Affiliations
- King's College London (GB)
- Corresponding author
- Strawbridge, Rebecca
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2017-05
- Volume
- Volume 13
- Pages
- 1245-1262
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- OpenAlex
- W3141564337
- Cited by
- 415
- References
- 212
- Citations by year
- 2026: 35 · 2025: 55 · 2024: 57 · 2023: 36 · 2022: 38 · 2021: 55 · 2020: 50 · 2019: 40 · 2018: 43 · 2017: 5
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- Research Portal (King's College London) (submittedVersion, cc-by-nc)
- Funders
- South London and Maudsley NHS Foundation Trust
- Wellcome Trust
- National Institute for Health and Care Research (NF-SI-0616-10091)
- King's College London
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- depression biomarkers, major depressive disorder, inflammation, neurotrophic factors, metabolic biomarkers, neurotransmitters, neuroendocrine system, epigenetics, transcriptomics, proteomics, metabolomics, neuroimaging, treatment response prediction, patient stratification, personalized medicine, depression heterogeneity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
